scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.LEUKRES.2007.01.018 |
P698 | PubMed publication ID | 17350683 |
P2093 | author name string | Takeshi Sugawara | |
Kazunori Murai | |||
Shigeki Ito | |||
Yoji Ishida | |||
Keijiro Suzuki | |||
Tatsuo Oyake | |||
Toshiyuki Uchiyama | |||
Shima Onodera | |||
Yasuhiko Tsukushi | |||
Yusei Aoki | |||
P433 | issue | 10 | |
P921 | main subject | myelodysplastic syndrome | Q954625 |
P304 | page(s) | 1343-1349 | |
P577 | publication date | 2007-03-12 | |
P1433 | published in | Leukemia Research | Q15716445 |
P1476 | title | Clinical significance of high-Km 5'-nucleotidase (cN-II) mRNA expression in high-risk myelodysplastic syndrome | |
P478 | volume | 31 |
Q38110693 | Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases. |
Q35587260 | Cytosolic 5'-nucleotidase II interacts with the leucin rich repeat of NLR family member Ipaf. |
Q35265653 | Genetic variants in cytosolic 5'-nucleotidase II are associated with its expression and cytarabine sensitivity in HapMap cell lines and in patients with acute myeloid leukemia. |
Q92661860 | MOB (Mps one Binder) Proteins in the Hippo Pathway and Cancer |
Q37871662 | MOB control: reviewing a conserved family of kinase regulators |
Q28478308 | Structural insights into the inhibition of cytosolic 5'-nucleotidase II (cN-II) by ribonucleoside 5'-monophosphate analogues |
Q86478970 | [NT5C2 expression in children with acute leukemia and its clinical significance] |
Search more.